Review of preclinical and clinical studies of using cell‐based therapy for secondary lymphedema

Secondary lymphedema is associated with impaired lymph fluid drainage and remains incurable. Alternatively, cell‐based therapy may pave the way for lymphedema treatment. We found 11 animal and seven human studies had been conducted from 2008 to 2018. Most studies showed great potential for this treatment modality. Emerging studies have focused on novel techniques, such as coupling cell therapy with lymph node transfer, or adding growth factors to cell therapy.

• Publication year

  2019

• Venue

  Journal of Surgical Oncology

• Publication date

  2019-08-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.25661PMID 31385308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology.

  2020cited by this paper
• Lymphedema

  2020cited by this paper
• Increased insulin-like growth factor 1 production by polyploid adipose stem cells promotes growth of breast cancer cells

  2018cited by this paper
• Stem Cell Therapy Using Bone Marrow-Derived Mononuclear Cells in Treatment of Lower Limb Lymphedema: A Randomized Controlled Clinical Trial

  2018cited by this paper
• Validity of the Novel Taiwan Lymphoscintigraphy Staging and Correlation of Cheng Lymphedema Grading for Unilateral Extremity Lymphedema

  2018cited by this paper
• Multipotent Adult Progenitor Cells Support Lymphatic Regeneration at Multiple Anatomical Levels during Wound Healing and Lymphedema

  2018cited by this paper
• Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence

  2018cited by this paper
• Exosomes from Adipose-Derived Stem Cells Promotes VEGF-C-Dependent Lymphangiogenesis by Regulating miRNA-132/TGF-β Pathway

  2018cited by this paper
• Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin

  2018cited by this paper
• Concise Review: A Safety Assessment of Adipose‐Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events

  2017cited by this paper
• Adipose-Derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis

  2017cited by this paper
• Human Adipose‐Derived Mesenchymal Stem Cell‐Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis

  2017cited by this paper
• Mesenchymal Stem Cells: Time to Change the Name!

  2017cited by this paper
• Incidence of lower limb lymphedema after vulvar cancer

  2017cited by this paper
• Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine

  2017cited by this paper
• Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer.

  2017cited by this paper
• Treatment of Breast Cancer‐Related Lymphedema with Adipose‐Derived Regenerative Cells and Fat Grafts: A Feasibility and Safety Study

  2017cited by this paper
• Adipose‐Derived Stem Cells Support Lymphangiogenic Parameters In Vitro

  2016cited by this paper
• The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology.

  2016cited by this paper
• Current Treatments for Breast Cancer-Related Lymphoedema: A Systematic Review

  2016cited by this paper
• Lymphedema: Complete Medical and Surgical Management

  2016cited by this paper
• Lymphedema surgery: Patient selection and an overview of surgical techniques

  2016cited by this paper
• Cell‐Assisted Lipotransfer Using Autologous Adipose‐Derived Stromal Cells for Alleviation of Breast Cancer‐Related Lymphedema

  2016cited by this paper
• Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function.

  2016cited by this paper
• Impact of platelet rich plasma and adipose stem cells on lymphangiogenesis in a murine tail lymphedema model.

  2015cited by this paper
• A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer

  2015cited by this paper
• Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.

  2015cited by this paper
• Adipose-Derived Stem Cells Promote Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells In Vitro by Secreting Lymphangiogenic Factors

  2015cited by this paper
• Cell-Based Therapy for Therapeutic Lymphangiogenesis

  2015cited by this paper
• Lymphoscintigraphy for the assessment of autologous stem cell implantation in chronic lymphedema.

  2015cited by this paper
• Diabetes impairs the angiogenic potential of adipose-derived stem cells by selectively depleting cellular subpopulations

  2014cited by this paper
• Cell transplantation therapy for a rat model of secondary lymphedema.

  2014cited by this paper
• Modification of a Rodent Hindlimb Model of Secondary Lymphedema: Surgical Radicality versus Radiotherapeutic Ablation

  2013cited by this paper
• Diabetes impairs adipose tissue–derived stem cell function and efficiency in promoting wound healing

  2013cited by this paper
• Mitochondria and Cancer

  2013cited by this paper
• A Prospective Analysis of 100 Consecutive Lymphovenous Bypass Cases for Treatment of Extremity Lymphedema

  2013cited by this paper
• Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.

  2012cited by this paper
• Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia

  2012cited by this paper
• Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy

  2012influential reference
• Indocyanine Green (ICG) Lymphography Is Superior to Lymphoscintigraphy for Diagnostic Imaging of Early Lymphedema of the Upper Limbs

  2012cited by this paper
• Therapeutic Lymphangiogenesis With Implantation of Adipose‐Derived Regenerative Cells

  2012cited by this paper
• Experimental Lymphedema: Can Cellular Therapies Augment the Therapeutic Potential for Lymphangiogenesis?

  2012cited by this paper
• Regulation of Adipogenesis by Lymphatic Fluid Stasis: Part I. Adipogenesis, Fibrosis, and Inflammation

  2012cited by this paper
• Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study.

  2011cited by this paper
• Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.

  2011cited by this paper
• Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition.

  2011cited by this paper
• Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema.

  2011cited by this paper
• Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

  2010cited by this paper
• Cell therapy for the treatment of lower limb lymphedema. Case report

  2010cited by this paper
• A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke

  2010cited by this paper
• Mesenchymal stem cells for acute lung injury: preclinical evidence.

  2010cited by this paper
• Emerging therapy for improving wound repair of severe radiation burns using local bone marrow‐derived stem cell administrations

  2010cited by this paper
• Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.

  2009cited by this paper
• The diagnosis and treatment of peripheral lymphedema.

  2009cited by this paper
• Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma

  2009cited by this paper
• Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo

  2009cited by this paper
• Stem cell‐based cell therapy in neurological diseases: A review

  2009cited by this paper
• Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

  2008cited by this paper
• Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema.

  2008cited by this paper
• Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model.

  2007cited by this paper
• Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.

  2007cited by this paper
• Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance

  2006cited by this paper
• Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.

  2005cited by this paper
• Microsurgical Techniques for Lymphedema Treatment: Derivative Lymphatic-Venous Microsurgery

  2004cited by this paper
• The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.

  2003cited by this paper
• Incidence of breast carcinoma‐related lymphedema

  1998cited by this paper
• Revista cubana de hematología inmunología y hemoterapia

  1985cited by this paper
• Competing Interests: This work was

  year unknowncited by this paper

• Mesenchymal stem cell therapy for breast cancer-related secondary lymphedema (Review)

  2025cites this paper
• Tissue‐Engineered Therapeutics for Lymphatic Regeneration: Solutions for Myocardial Infarction and Secondary Lymphedema

  2025cites this paper
• Lipid Nanoparticle Library Screen Reveals Lymphatic Endothelial Cell-Targeting Lipid Nanoparticle for Delivering Vascular Endothelial Growth Factor C mRNA after Lymphatic Injury

  2025cites this paper
• Clinical outcome is unlinked to injection of adipose-derived regenerative cells in the axilla of breast cancer-related lymphedema patients

  2024cites this paper
• Lymphatic endothelial cell-targeting lipid nanoparticles delivering VEGFC mRNA improve lymphatic function after injury

  2024cites this paper
• No Clinical Efficacy of Adipose-Derived Regenerative Cells and Lipotransfer in Breast Cancer–Related Lymphedema: A Double-Blind Placebo-Controlled Phase II Trial

  2024cites this paper
• Conservative medical intervention as a complement to CDT for BCRL therapy: a systematic review and meta-analysis of randomized controlled trials

  2024cites this paper
• Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema

  2022cites this paper
• In Vitro Induction of Human Dental Pulp Stem Cells to Lymphatic Endothelial Cells

  2022cites this paper
• Lentiviral overexpression of VEGFC in transplanted MSCs leads to resolution of swelling in a mouse tail lymphedema model

  2022cites this paper
• Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics

  2022cites this paper
• Low-intensity pulsed ultrasound promotes mesenchymal stem cell transplantation-based articular cartilage regeneration via inhibiting the TNF signaling pathway

  2021cites this paper
• Wnt Signaling Regulates the Lymphatic Endothelial Transdifferentiation of Adipose-Derived Stromal Cells In Vitro

  2021cites this paper
• Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis

  2021cites this paper
• Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis

  2021cites this paper
• EUROPEAN GROUP OF LYMPHOLOGY LATIN-MEDITERRANEAN CHAPTER OF ISL SOCIETÀ ITALIANA DI LINFANGIOLOGIA CZECH SOCIETY OF LYMPHOLOGY ROMANIAN SOCIETY OF LYMPHOLOGY GREEK SOCIETY OF LYMPHOLOGY TURK SOCIETY OF LYMPHOLOGY THE EUROPEAN JOURNALOF LYMPHOLOGYAND RELATED PROBLEMS (EJLRP)

  2021cites this paper
• In situ repair abilities of human umbilical cord–derived mesenchymal stem cells and autocrosslinked hyaluronic acid gel complex in rhesus monkeys with intrauterine adhesion

  2020cites this paper
• Stem Cell Therapy for Lymphedema

  2020cites this paper
• Therapeutic Potential of Mesenchymal Stem Cells for Postmastectomy Lymphedema: A Literature Review

  2020influential citation
• TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model

  2020cites this paper
• Adipose-derived stem cell therapy shows promising results for secondary lymphedema

  2020cites this paper
• Adipose-Derived Stem Cells Promote Intussusceptive Lymphangiogenesis by Restricting Dermal Fibrosis in Irradiated Tissue of Mice

  2020cites this paper
• Update October 2019

  2019cites this paper
• Hypoxia Exacerbates Inflammatory Acute Lung Injury via the Toll-Like Receptor 4 Signaling Pathway

  2018cites this paper
• SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells

  2017cites this paper
• SMAD 3 and SMAD 4 have a more dominant role than SMAD 2 in TGF β-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells

  2017cites this paper